Molecular Targeting Technologies and Singapore's Theranostics Center Gain HSA Approval for EBTATE® Trial in Nasopharyngeal Cancer

Somatostatin receptor 2 (SSTR2) is found in 81% of primary, recurrent, and metastatic NPC patients. EBTATE, the first patented and only long-acting peptide...

August 03, 2023 | Thursday | News
Clover Assistant Significantly Improves Early Chronic Kidney Disease Identification & Management

Clover Health (“Clover” or “the Company”) issued an analysis titled Clover Assistant Use and Diagnosis and Progression of Chronic K...

August 02, 2023 | Wednesday | News
Melinta Therapeutics Announces Commercial Availability of REZZAYO™ (rezafungin for injection)

Melinta Therapeutics, LLC  announced the availability of REZZAYO™ (rezafungin for injection), for the treatment of candidemia and invasive candi...

August 01, 2023 | Tuesday | News
FDA Streamlines Innovation for Opioid Use Disorder Devices

"The FDA continues to seek new ways to advance science to address the public health challenges that families and communities across the country face," said...

July 28, 2023 | Friday | News
Lenacapavir Shows Sustained Impact on HIV Patients' Quality of Life

Analyses Show Oral Bridging Maintains Virologic Suppression When Subcutaneous Lenacapavir Doses are Missed – Gilead Sciences, Inc. (Na...

July 26, 2023 | Wednesday | News
FDA Clears Numares Health Cardiovascular Diagnostic Test and Core Technology Platform

The FDA clearance also includes the company's core technology platform, the proprietary AXINON® System, that incorporates diagnostic testing algor...

July 26, 2023 | Wednesday | News
Lupin Emphasizes In-Home Cardiovascular Care with Digital Therapeutics

India based Lupin Digital Health and the American College of Cardiology (ACC) have announced a first-of-its-kind collaboration to deliver in-home cardiovas...

July 25, 2023 | Tuesday | News
AstraZeneca's Dapagliflozin Receives Expanded Approval for Heart Failure Treatment in India

AstraZeneca Pharma India has received extended indication approval from the Drugs Controller General of India (DCGI) for its drug, Dapagliflozin in the tre...

July 25, 2023 | Tuesday | News
Baxter Launches PERCLOT Absorbable Hemostatic Powder

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the launch of PERCLOT Absorbable Hemostatic Powder ...

July 25, 2023 | Tuesday | News
Menarini Group Receives Positive CHMP Opinion for ORSERDU® in ER+ Metastatic Breast Cancer

Each year in Europe more than 550,000 patients are diagnosed with breast cancer, of whom 70% have estrogen receptor (ER)-positive disease¹; more tha...

July 24, 2023 | Monday | News
ARMGO Pharma Enrolls First Patient in Phase 2 Trial of ARM210 for Catecholaminergic Polymorphic Ventricular Tachycardia Treatment

Trial to investigate the safety and efficacy of ARM210 for the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Lead molecule A...

July 21, 2023 | Friday | News
Gilead Announces $8 Million in Grant Funding for Viral Hepatitis Relink Program in the U.S.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is providing a total of $8 million in funding through a new grant program in the United States call...

July 21, 2023 | Friday | News
Integrated Biosciences Unveils Synthetic Biology Platform for Aging-Associated Stress Response Control

Optogenetic platform will be combined with AI at Integrated Biosciences to identify candidate anti-aging drugs Scientists demonstrate that cells make an i...

July 20, 2023 | Thursday | News
Junshi Biosciences' Toripalimab Accepted for First-line Treatment of Extensive-stage Small Cell Lung Cancer

According to data released by GLOBOCAN 2020, lung cancer is currently the most prevalent malignant tumor with the highest mortality rate in China. Small ce...

July 20, 2023 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close